By contrast, the expression of ASCT2 is not a significant prognostic factor of worse clinical outcomes in ovarian cancer, although positive expression of LAT1 is closely correlated with that of ASCT2 and CD98hc, and leads to significantly worse outcomes [91,92,93]. Here, SLC1A5 is linked to ovarian carcinoma.